René Kuijten, managing partner at Life Science Partners
February 11, 2022 11:04 AM ESTUpdated February 17, 11:15 AM
Financing

As it pre­pares to join EQT, Life Sci­ence Part­ners sur­pass­es €1B in­vest­ment mark

Josh Sullivan

Just a few months ago, the Eu­ro­pean in­vest­ment firm Life Sci­ence Part­ners an­nounced that it would be bought out by the pri­vate in­vest­ment group EQT …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times